Showing results (891-900 of 1,030) with videos related to
Sort By:
Pageof 103
Immunity & Ageing : I & A|November 26, 2024
Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapyEstelle Tran Van Hoi, Saskia J Santegoets, Simon P Mooijaart, et al.Msphere|August 18, 2023
Inactivation mechanisms of influenza A virus under pH conditions encountered in aerosol particles as revealed by whole-virus HDX-MSShannon C David, Oscar Vadas, Irina Glas, et al.The Journal of Biological Chemistry|July 11, 2015
The Soluble Periplasmic Domains of Escherichia coli Cell Division Proteins FtsQ/FtsB/FtsL Form a Trimeric Complex with Submicromolar AffinityMarjolein Glas, H Bart van den Berg van Saparoea, Stephen H McLaughlin, et al.Journal of Geriatric Oncology|October 16, 2024
Association of Glasgow Prognostic Score with frailty, mortality and adverse health outcomes in older patients with cancer: A prospective cohort studyYara van Holstein, Stella Trompet, Barbara C van Munster, et al.Frontiers in Microbiology|October 31, 2024
Dependence of aerosol-borne influenza A virus infectivity on relative humidity and aerosol compositionGhislain Motos, Aline Schaub, Shannon C David, et al.Gut|March 8, 2013
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatmentCornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich, et al.Iscience|January 4, 2024
KDM5B predicts temozolomide-resistant subclones in glioblastomaVivien Ullrich, Sarah Ertmer, Anna Baginska, et al.Journal of Geriatric Oncology|July 15, 2023
The association of blood biomarkers with treatment response and adverse health outcomes in older patients with solid tumors: A systematic reviewYara van Holstein, P Janne E van den Berkmortel, Stella Trompet, et al.Neurosurgery|March 13, 2018
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An Open-Label, Dose-Escalation Phase I/II TrialFrank A Giordano, Stefanie Brehmer, Bettina Mürle, et al.Rheumatology (Oxford, England)|July 31, 2015
Validity and measurement precision of the PROMIS physical function item bank and a content validity-driven 20-item short form in rheumatoid arthritis compared with traditional measuresMartijn A H Oude Voshaar, Peter M Ten Klooster, Cees A W Glas, et al.Pageof 103